FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133124893> ?p ?o ?g. }

• W3133124893 abstract "Abstract Background Poor availability and unaffordability of key access antibiotics may increase antimicrobial resistance in the community by promoting inappropriate antibiotic selection and abridged therapy compliance. Objective To check the prices, availability, and affordability of the World Health Organization (WHO) key access antibiotics in private sector pharmacies of Lahore, Pakistan. Methodology A survey of WHO key access antibiotics from WHO essential medicine list 2017 was conducted in private sector pharmacies of 4 different regions of Lahore employing adapted WHO/HAI methodology. The comparison of prices and availability between originator brands (OB) and lowest price generics (LPG) were conducted followed by the effect of medicine price differences on patient’s affordability. The data were analyzed using a preprogrammed WHO Microsoft excel workbook. Results The mean availability of OB products was 45.20% and the availability of LPGs was 40.40%. The OBs of co-amoxiclav, clarithromycin and metronidazole and LPGs of azithromycin and ciprofloxacin were easily available (100%) in all private sector pharmacies. Whereas, antibiotics like chloramphenicol, cloxacillin, nitrofurantoin, spectinomycin, and cefazolin were totally unavailable in all the surveyed pharmacies. The OBs and LPGs with high MPRs were ceftriaxone (OB; 15.31, LPG; 6.38) and ciprofloxacin (OB; 12.42, LPG; 5.77). The median of brand premium obtained was 38.7%, which varied between the lowest brand premium of 3.97% for metronidazole and highest for ceftriaxone i.e. 140%. The cost of standard treatment was 0.5 day’s wage (median) if using OB and 0.4 day’s wage (median) for LPG, for a lowest paid unskilled government worker. Treatment with OB and LPG was unaffordable for ciprofloxacin (OB; 2.4, LPG; 1.1) & cefotaxime (OB; 12.7, LPG; 8.1). Conclusion There is dire need to properly implement price control policies to better regulate fragile antibiotic supply system so that the availability of both OB and LPG of key access antibiotics should be increased. The prices could be reduced by improving purchasing efficiency, excluding taxes and regulating mark-ups. This could increase the affordability of patients to complete their antibiotic therapy with subsequent reduction in antimicrobial resistance." @default.
• W3133124893 created "2021-03-01" @default.
• W3133124893 creator A5014210739 @default.
• W3133124893 creator A5015962652 @default.
• W3133124893 creator A5017548992 @default.
• W3133124893 creator A5027183722 @default.
• W3133124893 creator A5028945413 @default.
• W3133124893 creator A5039066885 @default.
• W3133124893 creator A5045296053 @default.
• W3133124893 creator A5048164292 @default.
• W3133124893 creator A5048317573 @default.
• W3133124893 creator A5072781749 @default.
• W3133124893 creator A5080938613 @default.
• W3133124893 date "2021-02-16" @default.
• W3133124893 modified "2023-10-14" @default.
• W3133124893 title "WHO key access antibiotics prices, availability and affordability in private sector pharmacies in Pakistan" @default.
• W3133124893 cites W1845139821 @default.
• W3133124893 cites W1964139689 @default.
• W3133124893 cites W1965451022 @default.
• W3133124893 cites W1970723866 @default.
• W3133124893 cites W1995674118 @default.
• W3133124893 cites W2007052137 @default.
• W3133124893 cites W2027856465 @default.
• W3133124893 cites W2079507592 @default.
• W3133124893 cites W2086015900 @default.
• W3133124893 cites W2108638835 @default.
• W3133124893 cites W2110599421 @default.
• W3133124893 cites W2122047846 @default.
• W3133124893 cites W2124380283 @default.
• W3133124893 cites W2155553922 @default.
• W3133124893 cites W2165103822 @default.
• W3133124893 cites W2941642079 @default.
• W3133124893 cites W2953274188 @default.
• W3133124893 cites W2962851336 @default.
• W3133124893 cites W3092537611 @default.
• W3133124893 cites W4230556569 @default.
• W3133124893 doi "https://doi.org/10.1186/s12962-021-00263-x" @default.
• W3133124893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7885400" @default.
• W3133124893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33593366" @default.
• W3133124893 hasPublicationYear "2021" @default.
• W3133124893 type Work @default.
• W3133124893 sameAs 3133124893 @default.
• W3133124893 citedByCount "2" @default.
• W3133124893 countsByYear W31331248932021 @default.
• W3133124893 countsByYear W31331248932022 @default.
• W3133124893 crossrefType "journal-article" @default.
• W3133124893 hasAuthorship W3133124893A5014210739 @default.
• W3133124893 hasAuthorship W3133124893A5015962652 @default.
• W3133124893 hasAuthorship W3133124893A5017548992 @default.
• W3133124893 hasAuthorship W3133124893A5027183722 @default.
• W3133124893 hasAuthorship W3133124893A5028945413 @default.
• W3133124893 hasAuthorship W3133124893A5039066885 @default.
• W3133124893 hasAuthorship W3133124893A5045296053 @default.
• W3133124893 hasAuthorship W3133124893A5048164292 @default.
• W3133124893 hasAuthorship W3133124893A5048317573 @default.
• W3133124893 hasAuthorship W3133124893A5072781749 @default.
• W3133124893 hasAuthorship W3133124893A5080938613 @default.
• W3133124893 hasBestOaLocation W31331248931 @default.
• W3133124893 hasConcept C104863432 @default.
• W3133124893 hasConcept C121426985 @default.
• W3133124893 hasConcept C144133560 @default.
• W3133124893 hasConcept C162324750 @default.
• W3133124893 hasConcept C174802600 @default.
• W3133124893 hasConcept C2777396551 @default.
• W3133124893 hasConcept C2778512257 @default.
• W3133124893 hasConcept C2780408477 @default.
• W3133124893 hasConcept C501593827 @default.
• W3133124893 hasConcept C50522688 @default.
• W3133124893 hasConcept C512399662 @default.
• W3133124893 hasConcept C71924100 @default.
• W3133124893 hasConcept C86803240 @default.
• W3133124893 hasConcept C89423630 @default.
• W3133124893 hasConceptScore W3133124893C104863432 @default.
• W3133124893 hasConceptScore W3133124893C121426985 @default.
• W3133124893 hasConceptScore W3133124893C144133560 @default.
• W3133124893 hasConceptScore W3133124893C162324750 @default.
• W3133124893 hasConceptScore W3133124893C174802600 @default.
• W3133124893 hasConceptScore W3133124893C2777396551 @default.
• W3133124893 hasConceptScore W3133124893C2778512257 @default.
• W3133124893 hasConceptScore W3133124893C2780408477 @default.
• W3133124893 hasConceptScore W3133124893C501593827 @default.
• W3133124893 hasConceptScore W3133124893C50522688 @default.
• W3133124893 hasConceptScore W3133124893C512399662 @default.
• W3133124893 hasConceptScore W3133124893C71924100 @default.
• W3133124893 hasConceptScore W3133124893C86803240 @default.
• W3133124893 hasConceptScore W3133124893C89423630 @default.
• W3133124893 hasIssue "1" @default.
• W3133124893 hasLocation W31331248931 @default.
• W3133124893 hasLocation W31331248932 @default.
• W3133124893 hasLocation W31331248933 @default.
• W3133124893 hasOpenAccess W3133124893 @default.
• W3133124893 hasPrimaryLocation W31331248931 @default.
• W3133124893 hasRelatedWork W2004264983 @default.
• W3133124893 hasRelatedWork W2106840314 @default.
• W3133124893 hasRelatedWork W2120541013 @default.
• W3133124893 hasRelatedWork W2129372467 @default.
• W3133124893 hasRelatedWork W2137541664 @default.
• W3133124893 hasRelatedWork W2802246013 @default.
• W3133124893 hasRelatedWork W2890229351 @default.
• W3133124893 hasRelatedWork W2900586393 @default.

• next